These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1059362)

  • 21. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
    Lauzon GJ; Paterson AR; Belch AW
    Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of 1-beta-D-arabinofuranosylcytosine on the synthesis of phosphatidyl-dCMP.
    Iujvidin S; Feledi C; Medrano EE; Mordoh J
    Eur J Biochem; 1983 Feb; 130(2):293-6. PubMed ID: 6825694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.
    Rustum YM
    Cancer Res; 1978 Mar; 38(3):543-9. PubMed ID: 203383
    [No Abstract]   [Full Text] [Related]  

  • 26. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS; Covey JM
    J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms.
    Uchida K; Kreis W
    Biochem Pharmacol; 1969 May; 18(5):1115-28. PubMed ID: 5789778
    [No Abstract]   [Full Text] [Related]  

  • 28. Transformation of 5-aza-2'-deoxycytidine-3H and its incorporation in different systems of rapidly proliferating cells.
    Cihák A
    Eur J Cancer (1965); 1978 Feb; 14(2):117-24. PubMed ID: 624309
    [No Abstract]   [Full Text] [Related]  

  • 29. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
    Jekunen A
    Med Biol; 1987; 65(4):203-8. PubMed ID: 3437781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic parameters of 1-beta-D-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute nonlymphocytic leukemia treated with conventional and high-dose ara-C.
    Rustum YM; Riva C; Preisler HD
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):141-8. PubMed ID: 3589689
    [No Abstract]   [Full Text] [Related]  

  • 31. The biosynthesis of thymidylic acid. II. Preliminary studies with calf thymus extracts.
    WHITTAKER VK; BLAKLEY RL
    J Biol Chem; 1961 Mar; 236():838-41. PubMed ID: 13784934
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical changes in progressive muscular dystrophy. XIII. Nucleic acids, proteins, and total nucleotides in the thymus and spleen of dystrophic mice.
    Srivastava U; Sebag M; Thakur M
    Can J Biochem Cell Biol; 1985 May; 63(5):325-32. PubMed ID: 2410088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside.
    Kessel D; Hall TC; Wodinsky I
    Science; 1967 Jun; 156(3779):1240-1. PubMed ID: 6025544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma half-life of cytosine arabinoside in patients with leukaemia--the effect of uridine.
    Baguley BC; Falkenhaug EM
    Eur J Cancer (1965); 1975 Jan; 11(1):43-9. PubMed ID: 1055682
    [No Abstract]   [Full Text] [Related]  

  • 36. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
    Khwaja TA; Kigwana LJ; Mian AM
    Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
    Ho DH
    Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302
    [No Abstract]   [Full Text] [Related]  

  • 38. Preferential incorporation of 3H-deoxycytidine into chicken bursal cells. Comparison of radiolabelled nucleosides as lymphoid cell markers in chickens and mice.
    Bäck R; Linna TJ
    Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):534-8. PubMed ID: 1180056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D; Peck C; Hilliard S; Wingo W
    Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.